Dallas, TX -- (SBWIRE) -- 02/28/2011 -- GBI Research, the leading business intelligence provider, has released its latest research, “Oncology Market in China to 2017 – Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market”, which provides insights into oncology sales and price forecasts until 2017. The report also examines the Chinese oncology treatment usage patterns.
In addition, the report also includes insights into the oncology R&D pipeline. The report provides an in-depth analysis of the top five oncology therapeutic indications, which are breast cancer, colorectal cancer, prostate cancer, lung cancer and Non-Hodgkin’s Lymphoma (NHL).
Scope
The scope of this report includes:
Data and analysis on the oncology market in the China
Annualized market data for the oncology market from 2002 to 2009, with forecasts to 2017.
Market data on the therapeutic landscape which covers lung cancer, breast cancer, colorectal cancer, non-hodgkin’s lymphoma and prostate cancer, including market size, market share, annual cost of therapy, sales volume and treatment usage patterns such as disease population and treated population.
Key drivers and restraints that have had a significant impact on the market and on each indication.
The regulatory landscape which covers major regulatory bodies in China, IPR protection, key regulations for conducting oncology research, key government initiatives and pricing and reimbursement scenario
The competitive landscape of the Chinese oncology market which includes companies such as Roche/Genentech, AstraZeneca, Simcere,
Merck and GlaxoSmithKline
Key M&A activities and Licensing Agreements that took place from 2004 to 2010 in the Chinese oncology market.
Reasons to buy
The report will enhance your decision making capability. It will allow you to
Align your product portfolio to the markets with high growth potential.
Develop market-entry and market expansion strategies by identifying the leading countries and therapeutic segments poised for strong growth.
Device a more tailored country strategy through the understanding of key drivers and barriers of the region’s pharmaceutical market.
Develop key strategic initiatives by understanding the key focus areas of leading companies.
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.
Buy Now: Market Research
Browse All: China Market Research Reports
Oncology Market in China to 2017 – Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market
http://www.reportsnreports.com/reports/53804-oncology-market-in-china-to-2017-better-access-to-cancer-therap.html
Related Reports
Biomarkers in Cancer Research – High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth
Cancer Colorectal Cancer or Colon Cancer Therapy Area Pipeline Report
Liver Cancer Therapeutics – Pipeline Assessment and Market Forecasts to 2017
Breast Cancer Therapeutics – Pipeline Assessment and Market Forecasts to 2017
Cervical Cancer Therapeutics – Pipeline Assessment and Market Forecasts to 2017
Bladder Cancer – Pipeline Assessment and Market Forecasts to 2017
Ovarian Cancer Therapeutics – Pipeline Assessment and Market Forecasts to 2017
Non-Small Cell Lung Cancer (NSCLC) – Pipeline Assessment and Market Forecasts to 2017
Head and Neck Cancer – Pipeline Assessment and Market Forecast to 2017
Oncology Market in India to 2017 – Limited Patient Affordability for High Priced Biologics Lowers Market Potential
About ReportsnReports
ReportsnReports houses a comprehensive online library of more than 50,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website:http://www.reportsnreports.com
http://reportsnreports.wordpress.com/